Package 0074-7402-13

Brand: depakote er

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 0074-7402-13
Digits Only 0074740213
Product NDC 0074-7402
Product ID 0074-7402_59a7fe63-4d4b-41da-b586-c51f0bd28509
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-7402-13)

Marketing

Marketing Status
Marketed Since 2000-08-04
Brand depakote er
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Depakote ER ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "59a7fe63-4d4b-41da-b586-c51f0bd28509", "openfda": {"upc": ["0300747402137", "0300747401130"], "unii": ["644VL95AO6"], "rxcui": ["1099563", "1099565", "1099569", "1099571"], "spl_set_id": ["0dc024ce-efc8-4690-7cb5-639c728fccac"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-7402-13)", "package_ndc": "0074-7402-13", "marketing_start_date": "20000804"}], "brand_name": "Depakote ER", "product_id": "0074-7402_59a7fe63-4d4b-41da-b586-c51f0bd28509", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0074-7402", "generic_name": "Divalproex Sodium", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Depakote", "brand_name_suffix": "ER", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "NDA021168", "marketing_category": "NDA", "marketing_start_date": "20000804", "listing_expiration_date": "20271231"}